Elevance Health（ELV）今日盘中股价大幅下挫11.58%，成为市场关注的焦点。
消息面上，尽管公司盘前发布的第二季度调整后每股收益和营收均超出市场预期，并小幅上调了全年盈利指引，但此次指引上调幅度未能达到投资者的高预期，令市场感到失望。同时，公司第二季度营业利润率从去年同期的4.9%大幅收窄至3.5%，利润率压缩引发了投资者对盈利能力的担忧。此外，公司首席执行官在电话会议中透露，预计在未来12至18个月内退出更多州的医疗补助（Medicaid）市场，这一战略性收缩可能影响其未来的营收基础。
其他因素也共同加剧了跌势。公司高管指出，其联邦医疗保险（Medicare）和奥巴马医改计划中的手术需求出现温和下降趋势。此外，该股在财报发布前已累积较大涨幅，存在“利好兑现”的压力。整个管理型保健护理板块今日也表现疲软，对股价形成拖累。多重利空因素叠加，导致该股盘中遭遇大幅抛售。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.